These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5447932)

  • 1. [Experience in local therapy of tubercular caverns and residual cavities with administrations of sealing materials].
    Gorvenko GG; Glasson AA; Kopel'man MIu; Sokolik IuI; Gubanova GF; Badretdinov RZ
    Probl Tuberk; 1970; 48(6):38-41. PubMed ID: 5447932
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early results of combined isoniazid and hydrocortisone in endobronchial therapy of caverns].
    DI GIUSEPPE P
    Ann Med Nav (Roma); 1957; 62(1):43-50. PubMed ID: 13445012
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of ultrasonic aerosols of streptomycin and isoniazid on the bronchial tree of patients with intrathoracic tuberculosis].
    Gerasin VG; Din RKh; Semenova EV; Svistunova VP; Druzhinina AIa
    Probl Tuberk; 1984 Apr; (4):53-5. PubMed ID: 6739462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Optimization of indirect endolymphatic injection of isoniazid in pulmonary tuberculosis].
    Peleneva IM; Gariaeva NA; Burukhina LV; Zavgorodniĭ IG; Shurygin AA; Gorovits GA; Miroshnikova IP; Barlamov OP
    Probl Tuberk; 2002; (11):24-6. PubMed ID: 12501792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative effects of combined and continuous streptomycin-PAS and streptomycin-PAS-isoniazid therapy on closure of tuberculous caverns].
    MOREAU F
    Acta Tuberc Belg; 1957 Oct; 48(5):382-6. PubMed ID: 13497820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Several possibilities of organizing multimodal treatment of patients with pulmonary tuberculosis].
    Savula MM; Kravchenko NS
    Probl Tuberk; 2001; (8):26-8. PubMed ID: 11767385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The action of streptomycin and isoniazid on tuberculous caverns].
    MASSOLA U
    Minerva Med; 1958 Sep; 49(73):3471-89. PubMed ID: 13600164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of residual caverns after pneumonectomy].
    TELLINI M; BRUNI F
    Lotta Tuberc; 1957 Jun; 27(6):508-13. PubMed ID: 13476785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Remote results of the use of short-term artificial pneumothorax and intravenous intermittent chemotherapy in tuberculosis].
    Ursov IG; Kuzina LN; Bolganova MN
    Sov Med; 1980; (3):3-5. PubMed ID: 6966426
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bullous cavities resulting from tuberculous caverns].
    GARBAGNI R; ZUCCHETTI B; GHIGO M
    Arch Tisiol Mal Appar Respir; 1956 Dec; 11(12):937-56. PubMed ID: 13412384
    [No Abstract]   [Full Text] [Related]  

  • 11. The problem of tubercular giant cavities and their treatment.
    SAEED AH
    Pak J Health; 1957 Jul; 7(2):73-7. PubMed ID: 13542044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
    Ubaĭdullaev AM; Belotserkovskiĭ VG
    Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
    Borisova MI; Stakhanov VA; Sharkova TI; Ivashchenko NA
    Probl Tuberk Bolezn Legk; 2003; (7):34-7. PubMed ID: 12939876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined regular chemotherapy and lesion management under bronchofiberscope in proliferative endobronchial tuberculosis].
    Zheng DY; Zhou R; Chen P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):492-3. PubMed ID: 16190411
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of regional lymphotropic therapy in the treatment of pulmonary tuberculosis in HIV-infected individuals].
    Panteleev AM; Ivanov AK; Vinogradova EN
    Probl Tuberk Bolezn Legk; 2004; (6):26-8. PubMed ID: 15315127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anatomical characteristics of residual caverns in tuberculous pneumonia treated with antibiotics].
    VIDAL J; FOURCADE J; GUIN JJ
    Montp Med; 1957; 52(1):73-5. PubMed ID: 13526628
    [No Abstract]   [Full Text] [Related]  

  • 17. Cycloserine and isoniazid in reduced dosage combination in the therapy of pulmonary tuberculosis.
    ROBITZEK EH; NENASHEV PK
    Antibiot Annu; 1956-1957; ():431-6. PubMed ID: 13425417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Artificial pneumothorax in the combined therapy of destructive pulmonary tuberculosis].
    Andrenko AA; Fedorova MV; Grishchenko NG; Tadzhieva NV
    Probl Tuberk; 1995; (1):43-5. PubMed ID: 7761382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problems connected with combination therapy of pulmonary tuberculosis; bacteriological results of monotherapy with isoniazid & combination therapy with isoniazid & streptomycin].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1958; 119(4):371-5; discussion 375-88. PubMed ID: 13607372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.